{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}],"title":"Pulse Rate, To Low"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}],"title":"Pulse Rate, To Normal or No Change"},{"categories":[{"measurements":[{"groupId":"OG000","value":"7"}]}],"title":"Pulse Rate, To High"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Temperature, To Low"},{"categories":[{"measurements":[{"groupId":"OG000","value":"23"}]}],"title":"Temperature, To Normal or No Change"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Temperature, To High"}],"denoms":[{"counts":[{"groupId":"OG000","value":"28"}],"units":"Participants"}],"description":"Vital signs (pulse rate and temperature) were measured after resting for at least 5 minutes in a supine or semi-recumbent position. The abnormal vital sign ranges were: For pulse rate (low \\<60 beats per minute \\[bpm\\] and high \\>100 bpm); For body temperature (\\<=35 degrees Celsius or \\>=38 degrees Celsius). Participants were counted in the worst case category that their value changed to (low, normal or high), unless there was no change in their category. Baseline was defined as the most recent, non-missing value prior to or on the first study treatment dose date.","groups":[{"description":"Participants were administered belantamab mafodotin with recommended phase 2 dose (RP2D) of 2.5 mg/kg in combination with 200 mg of pembrolizumab via IV infusion on Day 1 of each 21-day Cycle up to until disease progression, intolerable toxicity, informed consent withdrawal, or for a maximum of 35 cycles.","id":"OG000","title":"Main Study Phase- Part 2: Belantamab Mafodotin 2.5 mg/kg + Pembrolizumab 200 mg Expansion"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All Treated Population","reportingStatus":"POSTED","timeFrame":"Baseline (Day 1) and up to approximately 178 weeks","title":"Part 2 - Number of Participants With Worst-case Change From Baseline in Vital Signs: Pulse Rate and Body Temperature","type":"SECONDARY","unitOfMeasure":"Participants"}